Skip to main content
SpringerLink
Log in

Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The main objective of the meta-analysis was to investigate whether intratympanic steroid injections in combination with systemic steroids would provide an additional advantage over systemic steroid therapy (SST) alone in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). The results will provide a meaningful suggestion in clinical therapy of ISSNHL. The electronic database search was based on the database in OVID Medline, Embase and PubMed up to December 15, 2015 with the goal of identifying all available observational studies examining the effects of combination therapy and SST in ISSNHL patients. Observational studies that compared the pure tone average (PTA) improvement and recovery rate between combination therapy and SST group in ISSNHL patients were selected. Finally we have identified eight eligible studies that focused on comparing the combination therapy and SST in ISSNHL from designated researches. In the PTA improvement group, seven studies have been analyzed to compare the pooled mean differences between two therapy modalities and subgroups based on initial hearing loss and treatment delay. In the recovery rate group, six studies were calculated for pooled risk ratios and subgroup analysis was also conducted. Through our meta-analysis, we have reached the conclusion that combination therapy exhibited better outcomes in PTA improvement than SST alone, especially in severe-profound initial hearing loss cases. Combination therapy also showed advantages in recovery rate. Whether time of treatment delay would influence the PTA improvement and recovery rate requires further researches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Xenellis J et al (2006) Idiopathic sudden sensorineural hearing loss: prognostic factors. J Laryngol Otol 120(9):718–724

    Article  CAS  PubMed  Google Scholar 

  2. Chau JK et al (2010) Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 120(5):1011–1021

    PubMed  Google Scholar 

  3. Korpinar S et al (2011) Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 268(1):41–47

    Article  PubMed  Google Scholar 

  4. Battaglia A, Burchette R, Cueva R (2008) Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29(4):453–460

    Article  PubMed  Google Scholar 

  5. Edizer DT et al (2015) Recovery of idiopathic sudden sensorineural hearing loss. J Int Adv Otol 11(2):122–126

    Article  PubMed  Google Scholar 

  6. Giannoni B, Pagnini P, Vannucchi P (1998) Delayed endolymphatic hydrops. Acta Otorhinolaryngol Ital 18(4 Suppl 59):66–70

    CAS  PubMed  Google Scholar 

  7. Filipo R et al (2014) Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss. Audiol Neurootol 19(4):225–233

    Article  CAS  PubMed  Google Scholar 

  8. Castro Junior NP, Almeida CI, Campos CA (2007) Sudden sensorineural hearing loss and vertigo associated with arterial occlusive disease: three case reports and literature review. Sao Paulo Med J 125(3):191–195

    Article  PubMed  Google Scholar 

  9. Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106(12):772–776

    Article  CAS  PubMed  Google Scholar 

  10. Gianoli GJ, Li JC (2001) Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 125(3):142–146

    Article  CAS  PubMed  Google Scholar 

  11. Hunchaisri N, Chantapant S, Srinangyam N (2010) Intratympanic dexamethasone for refractory sudden sensorineural hearing loss. J Med Assoc Thail 93(12):1406–1414

    Google Scholar 

  12. Vidal CA et al (2006) Avascular necrosis of both hips and knees in a patient with ulcerative colitis treated for a long term with high-dose corticosteroids. Nutr Hosp 21(1):109–112

    Google Scholar 

  13. Alexander TH et al (2009) Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol 30(4):443–448

    Article  PubMed  Google Scholar 

  14. Plontke SK et al (2009) Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 119(2):359–369

    Article  CAS  PubMed  Google Scholar 

  15. Fu Y et al (2011) Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: clinical evaluation and laboratory investigation. Auris Nasus Larynx 38(2):165–171

    Article  PubMed  Google Scholar 

  16. Lavigne P, Lavigne F, Saliba I (2015) Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol 1–8. doi: 10.1007/s00405-015-3689-3

  17. Seggas I et al (2011) Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol 32(1):29–35

    Article  PubMed  Google Scholar 

  18. Erdur O, Kayhan FT, Cirik AA (2014) Effectiveness of intratympanic dexamethasone for refractory sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 271(6):1431–1436

    Article  PubMed  Google Scholar 

  19. Arastou S, Tajedini A, Borghei P (2013) Combined intratympanic and systemic steroid therapy for poor-prognosis sudden sensorineural hearing loss. Iran J Otorhinolaryngol 25(70):23–28

    PubMed  PubMed Central  Google Scholar 

  20. Koltsidopoulos P et al (2013) Intratympanic and systemic steroids for sudden hearing loss. Otol Neurotol 34(4):771–776

    Article  PubMed  Google Scholar 

  21. Lim HJ et al (2013) Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngol Head Neck Surg 148(1):121–127

    Article  PubMed  Google Scholar 

  22. Jadad AR et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12

    Article  CAS  PubMed  Google Scholar 

  23. Battaglia A et al (2014) A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up. Otol Neurotol 35(6):1091–1098

    Article  PubMed  Google Scholar 

  24. Arslan N et al (2011) Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Otol Neurotol 32(3):393–397

    Article  PubMed  Google Scholar 

  25. Gundogan O et al (2013) Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngol Head Neck Surg 149(5):753–758

    Article  PubMed  Google Scholar 

  26. Gunel C et al (2015) Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss. Auris Nasus Larynx 42(4):284–287

    Article  CAS  PubMed  Google Scholar 

  27. Silverstein H et al (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75(8):468–71, 474, 476 passim

  28. Siegel LG (1975) The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 8(2):467–473

    CAS  PubMed  Google Scholar 

  29. Kim SH et al (2015) Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study. Clin Otolaryngol 40(3):183–190

    Article  CAS  PubMed  Google Scholar 

  30. Garavello W et al (2012) Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otol Neurotol 33(5):724–729

    Article  PubMed  Google Scholar 

  31. Stachler RJ et al (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146(3 Suppl):S1–S35

    Article  PubMed  Google Scholar 

  32. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Memorial University of Newfoundland, 230 Elizabeth Ave, St. John’s, NF, A1B 3X9, Canada

    Yang Gao

  2. Princess Margaret Cancer Center, Techna Institute, University Health Network, 101 College Street, Toronto, ON, M5G 1L7, Canada

    Dong Liu

  3. Department of Otorhinolaryngology, Qilu Hospital, Shandong University, 107 West Wenhua Road, Jinan, 250012, China

    Dong Liu

  4. Key Laboratory of Otolaryngology, Ministry of Health, 44 West Wenhua Road, Jinan, 250012, China

    Dong Liu

Authors
  1. Yang Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong Liu.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Ethical standards

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, Y., Liu, D. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis. Eur Arch Otorhinolaryngol 273, 3699–3711 (2016). https://doi.org/10.1007/s00405-016-4041-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4041-2

Keywords

Search

Navigation